CHURCH & DWIGHT CO INC /DE/ CHD

Healthcare SIC 2840 - Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics NAICS Manufacturing › Chemical Manufacturing › Soap, Cleaning Compound, and Toilet Preparation Manufacturing › Soap and Cleaning Compound Manufacturing derived NYSE

We were founded in 1846 and incorporated in Delaware in 1925. We develop, manufacture and market a broad range of consumer household and personal care products and specialty products focused on animal and food production, chemicals and cleaners. Our well-recognized brands include ARM & HAMMER® baking soda, cat litter, laundry detergent, carpet deodorizer and other baking soda-based products; OXICLEAN® stain removers, cleaning solutions, laundry detergents and bleach alternatives; BATISTE® dry shampoo; WATERPIK® water flossers; THERABREATH® oral care products; HERO® acne treatment products; TOUCHLAND® hand sanitizers; TROJAN® condoms, lubricants and vibrators; FIRST RESPONSE® home pregnancy and ovulation test kits; NAIR® depilatories; ORAJEL® oral analgesic; XTRA® laundry detergent; and ZICAM® cold shortening and relief products. Seven of those brands are designated as "power brands" because they compete in large categories, and we believe they have the potential for significant global expansion. Those seven brands are ARM & HAMMER®; OXICLEAN®; BATISTE®; WATERPIK®; THERABREATH®; HERO® and TOUCHLAND® and represent approximately 70% of our net sales and profits. Prior to the sale of our VITAFUSION® and L'IL CRITTERS® ("VMS") business at the end of 2025, we included VMS as an eighth "power brand."

Last close 105.19 2026-10-23
Market cap $24.95B 2026-06-30 share count
52-week range 81.33 - 108.93

Valuation FY2025 figures against the last close

P/S4.0x
P/E34.8x
P/FCF22.8x
EV/EBITDA20.2x
Dividend yield1.2%
Diluted EPS3.02

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $6.20B$6.11B$5.87B$5.38B$5.19B$4.90B$4.36B$4.15B$3.78B$3.49B
Cost of revenue $3.43B$3.32B$3.28B$3.13B$2.93B$2.68B$2.37B$2.31B$2.05B$1.90B
Gross profit $2.77B$2.79B$2.59B$2.25B$2.26B$2.21B$1.98B$1.84B$1.73B$1.59B
R&D $145.6M$139.7M$122.4M$110.0M$105.2M$102.6M$93.6M$89.7M$70.8M$63.2M
SG&A $988.3M$927.8M$889.8M$706.0M$606.7M$593.3M$628.8M$565.9M$542.7M$439.2M
Operating income $1.08B$807.1M$1.06B$597.8M$1.08B$1.03B$840.2M$791.7M$732.7M$724.2M
Interest expense $95.2M$95.0M$110.9M$89.6M$54.5M$61.0M$73.6M$79.4M$52.6M$27.7M
Pre-tax income $956.9M$756.3M$967.4M$523.3M$1.03B$973.8M$773.7M$719.5M$692.7M$705.9M
Income tax $220.1M$171.0M$211.8M$109.4M$204.2M$187.9M$157.8M$150.9M$50.7M$246.9M
Net income $736.8M$585.3M$755.6M$413.9M$827.5M$785.9M$615.9M$568.6M$743.4M$459.0M
EPS, basic 3.042.393.091.703.383.182.502.322.971.78
EPS, diluted 3.022.373.051.683.323.122.442.272.901.75
Shares, diluted (wtd. avg.) 244.3M246.9M247.6M246.3M249.6M252.2M252.1M250.7M256.1M262.1M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $409.0M$964.1M$344.5M$270.3M$240.6M$183.1M$155.7M$316.7M$278.9M$187.8M
Receivables $593.4M$600.8M$526.9M$422.0M$405.5M$398.8M$356.4M$345.3M$345.9M$287.0M
Inventory $534.8M$613.3M$613.3M$646.6M$535.4M$495.4M$417.4M$382.8M$330.7M$258.2M
Total current assets $1.60B$2.24B$1.53B$1.40B$1.23B$1.11B$956.4M$1.08B$1.00B$756.8M
Property, plant and equipment $822.8M$931.7M$927.7M$761.1M$652.7M$612.8M$598.2M$563.0M$607.7M$588.6M
Goodwill $2.63B$2.43B$2.43B$2.43B$2.27B$2.23B$2.08B$1.99B$1.96B$1.44B
Other intangibles $3.51B$2.89B$3.30B$3.43B$3.49B$3.11B$2.75B$2.27B$2.32B$1.43B
Total assets $8.91B$8.88B$8.57B$8.35B$8.00B$7.41B$6.66B$6.07B$6.01B$4.35B
Accounts payable $732.4M$705.1M$630.6M$666.7M$1.12B$1.02B$725.1M$738.7M$659.1M$568.9M
Short-term debt —$0$199.9M$0$699.4M$0$252.9M$596.5M$0$426.8M
Total current liabilities $1.50B$1.32B$1.42B$1.18B$2.08B$1.39B$1.09B$1.33B$935.0M$1.00B
Long-term debt $2.21B$2.20B$2.20B$2.60B$2.20B$1.81B$1.81B$1.51B$2.10B$693.4M
Total liabilities $4.91B$4.52B$4.71B$4.86B$4.76B$4.39B$3.99B$3.62B$3.80B$2.38B
Retained earnings $6.77B$6.32B$6.01B$5.52B$5.37B$4.79B$3.83B$3.85B$3.48B$2.93B
Total equity $4.00B$4.36B$3.86B$3.49B$3.23B$3.02B$2.67B$2.45B$2.22B$1.98B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $1.22B$1.16B$1.03B$885.2M$993.8M$990.3M$864.5M$763.6M$681.5M$655.3M
Depreciation and amortisation $247.4M$239.1M$225.2M$219.0M$219.1M$189.7M$176.4M$141.1M$125.4M$107.6M
Stock-based compensation $58.0M$59.2M$63.6M$32.3M$23.7M$21.5M$20.8M$23.3M$18.1M$16.0M
Capital expenditure $122.4M$179.8M$223.5M$178.8M$118.8M$98.9M$73.7M$60.4M$45.0M$49.8M
Investing cash flow -$616.9M-$183.3M-$234.3M-$728.6M-$682.0M-$608.1M-$553.5M-$112.1M-$1.30B-$354.6M
Financing cash flow -$1.16B-$343.4M-$725.6M-$120.9M-$252.1M-$360.1M-$472.9M-$609.0M$698.9M-$439.6M
Dividends paid $287.2M$277.0M$266.5M$255.0M$247.5M$237.3M$224.1M$213.3M$190.4M$183.0M
Buybacks $900.0M$0$300.1M$0$500.0M$300.0M$250.0M$200.0M$400.0M$400.0M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-048139.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 2B 4B 6B 8B Revenue, FY2016: 3.5B Gross profit, FY2016: 1.6B Net income, FY2016: 459M Revenue, FY2017: 3.8B Gross profit, FY2017: 1.7B Net income, FY2017: 743.4M Revenue, FY2018: 4.1B Gross profit, FY2018: 1.8B Net income, FY2018: 568.6M Revenue, FY2019: 4.4B Gross profit, FY2019: 2B Net income, FY2019: 615.9M Revenue, FY2020: 4.9B Gross profit, FY2020: 2.2B Net income, FY2020: 785.9M Revenue, FY2021: 5.2B Gross profit, FY2021: 2.3B Net income, FY2021: 827.5M Revenue, FY2022: 5.4B Gross profit, FY2022: 2.2B Net income, FY2022: 413.9M Revenue, FY2023: 5.9B Gross profit, FY2023: 2.6B Net income, FY2023: 755.6M Revenue, FY2024: 6.1B Gross profit, FY2024: 2.8B Net income, FY2024: 585.3M Revenue, FY2025: 6.2B Gross profit, FY2025: 2.8B Net income, FY2025: 736.8M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $3.49B $3.78B $4.15B $4.36B $4.90B $5.19B $5.38B $5.87B $6.11B $6.20B
Gross profit $1.59B $1.73B $1.84B $1.98B $2.21B $2.26B $2.25B $2.59B $2.79B $2.77B
Net income $459.0M $743.4M $568.6M $615.9M $785.9M $827.5M $413.9M $755.6M $585.3M $736.8M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced Item 2.02
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Other event Item 8.01
  • Results announced Item 2.02
  • Results announced Item 2.02
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • Material agreement terminated An agreement that mattered has ended. Often the other half of a deal that fell through. Item 1.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2840

TickerCompanyMarket capP/ERevenue growth
PG PROCTER & GAMBLE Co $374.28B 24.3x 3.3%
ECL ECOLAB INC. $80.88B 39.6x 2.2%
SCL STEPAN CO $1.45B 31.2x 7.0%
UL UNILEVER PLC — — —
WNW Meiwu Technology Co Ltd — — 4,368.0%
BYAH Park Ha Biological Technology Co., Ltd. — — 6.0%